DJIA 18,080.14 21.45 0.12%
NASDAQ 5,092.09 36.02 0.71%
S&P 500 2,117.69 4.76 0.23%
market minute promo

Vertex Pharmaceuticals (NASDAQ: VRTX)



company name or ticker
Company Photos
(Click to zoom)

3 Biotech Stocks to Buy in March

Our experts weigh in on why they like Vertex Pharmaceuticals, Neuralstem, and Intercept Pharmaceuticals.

Hemispherx Uses Ebola Tragedy to Raise Cash, Pay Executive Bonuses

Biotech M&A Outlook Boosted By AbbVie Deal, Says This RBC Analyst

Nasdaq 100 Movers: AAL, MYL

Today's Unusual Social Activity Stock: Vertex Pharmaceuticals (VRTX)

Biotech Stock Roundup: Orexigen Soars on Contrave Data, Amgen Scores in Study - Analyst Blog

3 Stocks Dragging In The Drugs Industry

Biotech Stock Roundup: Pharmacyclics Up on Buyout Rumors, Celgene Drug Label Expanded - Analyst B

Biotech Stock Roundup: Pharmacyclics Up on Buyout Rumors, Celgene Drug Label Expanded - Analyst Blog

Short Sellers Come Back To Biotech Stocks

PTC Therapeutics for Sale? Only to a Foolish, Risk-Blind Buyer

See More Articles...